Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
13%
OVERLAP
BY WEIGHT
46
# OF OVERLAPPING
HOLDINGS
VHT
415
HOLDINGS
12%
ALSO IN XPH
XPH
56
HOLDINGS
94%
ALSO IN VHT
SECTOR DRIFT (VHT minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 4.6% | 2.4% | 2.4% |
|
JOHNSON & JOHNSON | 9.1% | 2.4% | 2.4% |
|
PFIZER INC | 2.4% | 2.1% | 2.1% |
|
ELI LILLY & CO | 12.6% | 2.0% | 2.0% |
|
BRISTOL-MYERS SQUIBB CO | 1.9% | 2.3% | 1.9% |
VHT Overweight Relative to XPH
|
ELI LILLY & CO | 10.6% |
|
JOHNSON & JOHNSON | 6.7% |
|
ABBVIE INC | 6.2% |
|
UNITEDHEALTH GROUP INC | 4.1% |
|
AMGEN INC | 3.1% |
|
ABBOTT LABORATORIES | 3.0% |
|
GILEAD SCIENCES INC | 2.9% |
|
THERMO FISHER SCIENTIFIC INC | 2.8% |
|
INTUITIVE SURGICAL INC | 2.7% |
|
MERCK & CO. INC. | 2.2% |
VHT Underweight Relative to XPH
|
DEFINIUM THERAPEUTICS INC | -2.9% |
|
EDGEWISE THERAPEUTICS, INC. | -2.5% |
|
ROYALTY PHARMA PLC CLASS A | -2.4% |
|
PHIBRO ANIMAL HEALTH CORP-A | -2.3% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.2% |
|
LIGAND PHARMACEUTICALS-CL B | -2.2% |
|
SUPERNUS PHARMACEUTICALS INC | -2.2% |
|
INNOVIVA, INC. | -2.2% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.1% |
|
VIATRIS, INC. | -2.1% |